In Vitro Bactericidal Activity of the Antiprotozoal Drug Miltefosine against <i>Streptococcus pneumoniae</i> and Other Pathogenic Streptococci

Daniel Llull(Consejo Superior de Investigaciones Científicas), Ernesto Garcı́a(Consejo Superior de Investigaciones Científicas), Luís Rivas(Centro de Investigaciones Biológicas Margarita Salas)
Antimicrobial Agents and Chemotherapy
March 13, 2007
10.1128/aac.01428-06
Cited by 38

Related Papers

Substrate oxidation sites in versatile peroxidase and other basidiomycete peroxidases
|Journal of Experimental Botany|2008|280
Sequence and transcriptional analysis of a DNA region involved in the production of capsular polysaccharide in Streptococcus pneumoniae type 3
|Gene|1995|212
Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage
|FEMS Microbiology Reviews|2004|187
Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages.
|Proceedings of the National Academy of Sciences|1988|173
A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA.
|Nature Structural Biology|2001|171